ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Hutchinson Center Receives NCI Grant For Immunotherapy Network

October 15, 2010

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

White House Budget asks $1.101 Billion For NCI In FY 1985; R01-P01 Pool Goes Up By 5.5 Percent

February 10, 1984

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000